Jeffrey Jacobs's Insider Trades & SAST Disclosures
Jeffrey Jacobs's most recent trade in Cronos Group Inc was a trade of 59,191 RESTRICTED STOCK UNITS done . Disclosure was reported to the exchange on March 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeffrey Jacobs.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 59,191 | 375,820 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 59,191 | 387,271 (0%) | 0% | 0 | COMMON SHARES | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 31,766 | 335,777 (0%) | 0% | 0 | COMMON SHARES | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 31,766 | 435,011 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.89 per share. | 15 Mar 2025 | 14,413 | 372,858 (0%) | 0% | 1.9 | 27,241 | COMMON SHARES |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.89 per share. | 15 Mar 2025 | 7,697 | 328,080 (0%) | 0% | 1.9 | 14,547 | COMMON SHARES |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 195,538 | 466,777 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2025 | 60,536 | 321,828 (0%) | 0% | 0 | COMMON SHARES | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2025 | 60,536 | 271,239 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.99 per share. | 08 Mar 2025 | 17,817 | 304,011 (0%) | 0% | 2.0 | 35,456 | COMMON SHARES |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 17,473 | 50,131 (0%) | 0% | 0 | Common Stock | |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.99 per share. | 28 Feb 2025 | 1,783 | 32,658 (0%) | 0% | 62.0 | 110,528 | Common Stock |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.99 per share. | 28 Feb 2025 | 840 | 34,441 (0%) | 0% | 62.0 | 52,072 | Common Stock |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.43 per share. | 24 Feb 2025 | 907 | 35,281 (0%) | 0% | 64.4 | 58,438 | Common Stock |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 938 | 0 | - | - | Performance Units | |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 938 | 36,188 (0%) | 0% | 0 | Common Stock | |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 500 | 0 | - | - | Option (right to buy) | |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 63.37 per share. | 15 Oct 2024 | 500 | 34,074 (0%) | 0% | 63.4 | 31,685 | Common Stock |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.58 per share. | 15 Oct 2024 | 500 | 34,574 (0%) | 0% | 17.6 | 8,790 | Common Stock |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 63.37 per share. | 15 Oct 2024 | 143 | 34,074 (0%) | 0% | 63.4 | 9,062 | Common Stock |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 61.10 per share. | 01 Oct 2024 | 376 | 34,217 (0%) | 0% | 61.1 | 22,974 | Common Stock |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 59,191 | 331,775 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 59,191 | 284,801 (0%) | 0% | 0 | COMMON SHARES | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 31,767 | 238,227 (0%) | 0% | 0 | COMMON SHARES | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 31,767 | 390,966 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share. | 15 Mar 2024 | 23,509 | 261,292 (0%) | 0% | 2.0 | 46,548 | COMMON SHARES |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share. | 15 Mar 2024 | 12,617 | 225,610 (0%) | 0% | 2.0 | 24,982 | COMMON SHARES |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 181,627 | 422,733 | - | - | RESTRICTED STOCK UNITS | |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 824 | 0 | - | - | Performance Units | |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 824 | 34,468 (0%) | 0% | - | Common Stock | |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.92 per share. | 08 Mar 2024 | 253 | 34,215 (0%) | 0% | 66.9 | 16,931 | Common Stock |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.92 per share. | 08 Mar 2024 | 253 | 33,644 (0%) | 0% | 66.9 | 16,931 | Common Stock |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 14,652 | 33,897 (0%) | 0% | 0 | Common Stock | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 7,017 | 209,680 (0%) | 0% | 0 | COMMON SHARES | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 7,017 | 241,106 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.84 per share. | 01 Mar 2024 | 3,220 | 206,460 (0%) | 0% | 2.8 | 9,145 | COMMON SHARES |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,096 | 1,096 | - | - | Performance Units | |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.05 per share. | 28 Feb 2024 | 840 | 19,464 (0%) | 0% | 71.1 | 59,682 | Common Stock |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.05 per share. | 28 Feb 2024 | 219 | 19,245 (0%) | 0% | 71.1 | 15,560 | Common Stock |
| Dayforce Inc | Jacobs Jeffrey S. | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2024 | 1,176 | 20,673 (0%) | 0% | - | Common Stock | |
| Dayforce Inc | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2024 | 1,176 | 1,176 | - | - | Performance Units | |
| Dayforce Inc | S. Jeffrey Jacobs | Head of Acct & Fin Reporting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.42 per share. | 24 Feb 2024 | 507 | 19,497 (0%) | 0% | 71.4 | 36,210 | Common Stock |
| Dayforce Inc | Jeffrey Jacobs S. | Head of Acct & Fin Reporting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.42 per share. | 24 Feb 2024 | 369 | 20,304 (0%) | 0% | 71.4 | 26,354 | Common Stock |
| Dayforce Inc | S. Jacobs Jeffrey | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 713 | 0 | - | - | Performance Units | |
| Dayforce Inc | Jacobs S. Jeffrey | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 713 | 20,004 (0%) | 0% | - | Common Stock | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 12,411 | 208,719 (0%) | 0% | 0 | COMMON SHARES | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 12,411 | 248,123 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.49 per share. | 11 May 2023 | 6,056 | 202,663 (0%) | 0% | 2.5 | 15,079 | COMMON SHARES |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 57.82 per share. | 09 May 2023 | 159 | 19,029 (0%) | 0% | 57.8 | 9,193 | Common Stock |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 177,573 | 260,534 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 31,767 | 213,043 (0%) | 0% | 0 | COMMON SHARES | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 31,767 | 82,961 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 15 Mar 2023 | 16,735 | 196,308 (0%) | 0% | 2.7 | 45,519 | COMMON SHARES |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 823 | 19,299 (0%) | 0% | - | Common Stock | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 823 | 824 | - | - | Performance Units | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 71.69 per share. | 08 Mar 2023 | 255 | 18,476 (0%) | 0% | 71.7 | 18,281 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 71.69 per share. | 08 Mar 2023 | 255 | 19,044 (0%) | 0% | 71.7 | 18,281 | Common Stock |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 188,317 | 188,317 | - | - | COMMON SHARE OPTION (right to buy) | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 7,018 | 184,785 (0%) | 0% | 0 | COMMON SHARES | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 7,018 | 114,728 | - | - | RESTRICTED STOCK UNITS | |
| Cronos Group Inc | Jeffrey Jacobson | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.96 per share. | 01 Mar 2023 | 3,509 | 181,276 (0%) | 0% | 3.0 | 10,387 | COMMON SHARES |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 8,227 | 18,755 (0%) | 0% | 0 | Common Stock | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 845 | 845 | - | - | Performance Units | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 72.88 per share. | 28 Feb 2023 | 24 | 18,731 (0%) | 0% | 72.9 | 1,749 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 1,176 | 2,352 | - | - | Performance Units | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 1,176 | 10,889 (0%) | 0% | - | Common Stock | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 565 | 9,918 (0%) | 0% | - | Common Stock | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 565 | 0 | - | - | Performance Units | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 72.44 per share. | 24 Feb 2023 | 489 | 9,353 (0%) | 0% | 72.4 | 35,423 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 72.44 per share. | 24 Feb 2023 | 361 | 10,528 (0%) | 0% | 72.4 | 26,151 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 72.44 per share. | 24 Feb 2023 | 205 | 9,713 (0%) | 0% | 72.4 | 14,850 | Common Stock |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 16,400 | 13,600 | - | - | Options | |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Sale of securities on an exchange or to another person at price $ 16.07 per share. | 02 Jun 2022 | 16,400 | 100 (0%) | 0% | 16.1 | 263,548 | Class A Common Stock |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.50 per share. | 02 Jun 2022 | 16,400 | 16,500 (0%) | 0% | 14.5 | 237,800 | Class A Common Stock |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Sale of securities on an exchange or to another person at price $ 16.06 per share. | 02 Jun 2022 | 13,600 | 100 (0%) | 0% | 16.1 | 218,416 | Class A Common Stock |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.50 per share. | 02 Jun 2022 | 13,600 | 13,700 (0%) | 0% | 14.5 | 197,200 | Class A Common Stock |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 13,600 | 0 | - | - | Options | |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Other type of transaction at price $ 15.30 per share. | 16 May 2022 | 169 | 15,832 (0%) | 0% | 15.3 | 2,586 | Class A Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 53.00 per share. | 09 May 2022 | 163 | 9,699 (0%) | 0% | 53 | 8,639 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 823 | 1,647 | - | - | Performance Units | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 823 | 10,033 (0%) | 0% | - | Common Stock | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 593 | 0 | - | - | Performance Units | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 593 | 9,427 (0%) | 0% | - | Common Stock | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 62.48 per share. | 08 Mar 2022 | 301 | 8,834 (0%) | 0% | 62.5 | 18,806 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 62.49 per share. | 08 Mar 2022 | 266 | 9,767 (0%) | 0% | 62.5 | 16,622 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 62.49 per share. | 08 Mar 2022 | 217 | 9,210 (0%) | 0% | 62.5 | 13,560 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 72.85 per share. | 01 Mar 2022 | 27 | 9,135 (0%) | 0% | 72.9 | 1,967 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 4,235 | 9,162 (0%) | 0% | 0 | Common Stock | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 4,235 | 4,235 | - | - | Performance Units | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 678 | 678 | - | - | Performance Units | |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Other type of transaction at price $ 14.54 per share. | 15 Feb 2022 | 170 | 15,663 (0%) | 0% | 14.5 | 2,472 | Class A Common Stock |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 18,000 | 18,000 | - | - | Options | |
| Ardelyx Inc | Jeffrey Jacobs | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 22 Nov 2021 | 5,000 | 120,237 (0%) | 0% | 1.0 | 4,882 | Common Stock |
| Ardelyx Inc | Jeffrey Jacobs | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.99 per share. | 22 Nov 2021 | 754 | 119,483 (0%) | 0% | 1.0 | 748 | Common Stock |
| Ardelyx Inc | Jeffrey Jacobs | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 15 Nov 2021 | 5,000 | 125,237 (0%) | 0% | 1.1 | 5,650 | Common Stock |
| Donegal Group Inc. - Ordin... | Jeffrey Alan Jacobsen | Sr. Vice President | Other type of transaction at price $ 14.46 per share. | 15 Nov 2021 | 169 | 15,493 (0%) | 0% | 14.5 | 2,444 | Class A Common Stock |
| Ardelyx Inc | Jeffrey Jacobs | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 08 Nov 2021 | 2,166 | 130,237 (0%) | 0% | 1.2 | 2,556 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 03 Sep 2021 | 1,000 | 4,840 (0%) | 0% | 115 | 115,000 | Common Stock |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 1,000 | 1,125 | - | - | Option (right to buy) | |
| Ceridian HCM Holding Inc. | Jeffrey S. Jacobs | Head of Acct & Fin Reporting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.82 per share. | 03 Sep 2021 | 1,000 | 5,840 (0%) | 0% | 16.8 | 16,820 | Common Stock |
| Ardelyx Inc | Jeffrey Jacobs | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 20 Aug 2021 | 741 | 127,697 (0%) | 0% | 1.3 | 978 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges